Novel method of use
AssigneeGlaxoSmithKlline Intellectual Property Development
InventorsJavier COTE-SIERRA, Susan H. SMITH, Steven M. FREY
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel method of treatment of acne in a human patient in need thereof, comprising administering topically to said patient an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene (Compound 1) or a pharmaceutically acceptable salt thereof.
Claims18
A method of treating acne in a patient in need thereof comprising administering to said patient a topically effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene, or a pharmaceutically acceptable salt thereof.
A method of suppressing the production of IL-17A in a human in need thereof comprising topically administering to said human an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene, or a pharmaceutically acceptable salt thereof.
A method of suppressing keratinocyte hyperproliferation via induced apoptosis in a human in need thereof comprising topically administering to said human an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene, or a pharmaceutically acceptable salt thereof.
A method of promoting keratinocyte cell death in a human in need thereof, comprising topically administering to said human an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene, or a pharmaceutically acceptable salt thereof.
16-17. (canceled)
A method of treating acne in a patient in need thereof comprising administering to said patient a topically effective amount of the pharmaceutical composition comprising 3,5-Dihydroxy-4-isopropyl-trans-stilbene, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent.
(canceled)
Dependencies are inferred from the claim text.